Medical Cannabis Advocacy in Mexico During the 1950s

Why the 1950s were a decade of prohibition consolidation, not medical reform.

Automated fact-check pass
6 cited sources
Published
Last reviewed
How this page was made
↯ The honest take

There was no organized medical cannabis advocacy in Mexico during the 1950s. That decade was one of enforcement expansion and international alignment toward absolute prohibition. The confusion often arises from Leopoldo Salazar Viniegra's real but earlier 1938–1940 medical-model reform, which was rolled back before 1950. Organized advocacy in Mexico actually began in the 2010s through amparo litigation.

What Mexico inherited: the 1920–1940 context

To understand why the 1950s saw consolidation rather than reform, you need to know what came before.

Mexico prohibited cannabis sale and recreational use in 1920 through a federal sanitary decree—seven years before the United States did the same in 1927 [1]. Cultivation was banned in 1927. By the late 1930s, Dr. Leopoldo Salazar Viniegra, head of the federal narcotics service, became the most significant voice for medical-model drug reform. In 1938–1940, he pushed through the Reglamento Federal de Toxicomanías, which briefly treated addiction as a public health matter and allowed state-run dispensaries for addicts [2]. Strong evidence

That reform lasted less than six months. U.S. pressure and domestic political opposition forced its suspension in July 1940 [2]. By January 1950, the reformist wing had been sidelined entirely. What remained was a purely enforcement regime.

The 1950s: enforcement and international alignment

The decade of the 1950s in Mexican drug policy is best characterized as consolidation of prohibition, not medical reform. Key developments:

Enforcement expansion. The Procuraduría General de la República expanded its narcotics division. Cannabis eradication campaigns intensified in Sinaloa, Durango, and Guerrero, often coordinated with U.S. Federal Bureau of Narcotics agents. Strong evidence

International alignment. Mexico participated in the 1953 Opium Protocol negotiations and moved toward the framework that would become the 1961 Single Convention on Narcotic Drugs, which classified cannabis as a Schedule IV substance with no recognized medical use [3]. Strong evidence

Medical literature: what the archives show. Mexican medical journals from the 1950s—including Gaceta Médica de México—contain very few clinical articles on cannabis. When cannabis did appear in medical writing, it was typically framed as a cause of psychosis or delinquency, echoing earlier 20th-century physicians like Francisco Castañeda [4]. Weak / limited

There was no organized 1950s Mexican patient-advocacy movement for medical cannabis. Strong evidence

Why a myth of 1950s medical advocacy persists

Several historical facts often get compressed or misdated in popular retellings:

Salazar Viniegra's 1938–1940 reform is sometimes backdated. His work on the Reglamento Federal de Toxicomanías is real and historically important—but it happened in the late 1930s and was suspended in 1940, not during the 1950s. Because it was written about retrospectively in the 1950s and later, some accounts conflate the two decades [2].

Folk medical use continued, but was not "advocacy." Cannabis (called Santa Rosa or la Santa María in some Indigenous and rural syncretic practices) continued to be used in traditional curanderismo in central and western Mexico through the 1950s and beyond [5]. Weak / limited This is a matter of folk medicine and cultural practice, not organized medical advocacy or clinical research.

Isaac Campos's historical work is sometimes misread. Campos's 2012 book Home Grown demonstrated that Mexico's anti-cannabis discourse was largely homegrown and predated heavy U.S. pressure [1]. Strong evidence This finding sometimes gets flipped in casual retellings into a claim that Mexico had a suppressed pro-cannabis medical tradition. That is not what Campos argues. Disputed

Key figures of the era and their actual roles

Leopoldo Salazar Viniegra (1898–1957). The most significant reformist voice in Mexican drug policy, but his active policy years were the late 1930s. He lived through the 1950s and died in 1957, but there is no evidence he published or advocated for cannabis reform during the 1950s itself [2]. Strong evidence

Mid-century public health officials like Fernando Rosenzweig and others in the health ministry focused on tuberculosis, polio eradication, and maternal and infant health—not cannabis reform.

U.S. counterparts and external pressure. Harry J. Anslinger of the Federal Bureau of Narcotics continued to shape Mexican policy from outside through diplomatic pressure throughout the 1950s. Strong evidence

If you encounter a specific claim about a 1950s Mexican doctor leading an organized medical cannabis campaign, look for a primary source. After a thorough search, we could not locate one.

Where the story resumes: 2010s onward

Organized medical cannabis advocacy in Mexico in any meaningful sense begins in the 2010s, driven by legal and constitutional challenges:

The historical through-line runs from Salazar Viniegra's 1940 suspension to the 2015 amparo—skipping the 1950s almost entirely. That gap is not an oversight. It reflects the actual historical record: the 1950s were a decade of enforcement consolidation, not reform. Strong evidence

Sources

How this page was made

Generation history

Nov 1, 2026
Fact-check pass — raised 10 flags
Nov 1, 2026
Revision
Jul 31, 2026
Fact-check pass — raised 2 flags
Jul 31, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.